Earlier this week the CIRM ICOC Board awarded $14.5 million to fund three translational stage research projects (TRAN1), whose goal is to support early development activities necessary for advancement to a clinical study or broad end use of a potential therapy. Although all three projects have their distinct area of focus, they all utilize CAR-based … Continue reading Latest CIRM TRAN1 awards focus on CAR-based cell therapy to treat cancer
invariant natural killer T cells
CIRM Board Approves Two New Discovery Research Projects for COVID-19
Dr. Karen Christman (left) and Dr. Lili Yang (right) This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new discovery research project as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of COVID-19 projects CIRM is supporting to 17, including three clinical trials. … Continue reading CIRM Board Approves Two New Discovery Research Projects for COVID-19
The Stem Cellar 